» Articles » PMID: 38434987

Identification of a LncRNA/circRNA-miRNA-mRNA Network in Nasopharyngeal Carcinoma by Deep Sequencing and Bioinformatics Analysis

Overview
Journal J Cancer
Specialty Oncology
Date 2024 Mar 4
PMID 38434987
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulating evidence indicates that non-coding RNAs (ncRNA), including long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), can function as competitive endogenous RNAs (ceRNAs) by binding to microRNAs (miRNAs) and regulating host gene expression at the transcriptional or post-transcriptional level. Dysregulation in ceRNA network regulation has been implicated in the occurrence and development of cancer. However, the lncRNA/circRNA-miRNA-mRNA regulatory network is still lacking in nasopharyngeal carcinoma (NPC). Differentially expressed genes (DEGs) were obtained from our previous sequencing data and Gene Expression Omnibus (GEO). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) were used to explore the biological functions of these common DEGs. Through a series of bioinformatic analyses, the lncRNA/circRNA-miRNA-mRNA network was established. In additional, the external data GSE102349 was used to test the prognostic value of the hub mRNAs through the Kaplan-Meier method. We successfully constructed a lncRNA/circRNA-miRNA-mRNA network in NPC, consisting of 16 lncRNAs, 6 miRNAs, 3 circRNAs and 10 mRNAs and found that three genes (TOP2A, ZWINT, TTK) were significantly associated with overall survival time (OS) in patients. The regulatory network revealed in this study may help comprehensively elucidate the ceRNA mechanisms driving NPC, and provide novel candidate biomarkers for evaluating the prognosis of NPC.

Citing Articles

Integrative bioinformatics analysis of high-throughput sequencing and in vitro functional analysis leads to uncovering key hub genes in esophageal squamous cell carcinoma.

Shen F, Liu X, Ding F, Yu Z, Shi X, Cheng L Hereditas. 2025; 162(1):38.

PMID: 40087784 DOI: 10.1186/s41065-025-00398-4.


The interplay of p16INK4a and non-coding RNAs: bridging cellular senescence, aging, and cancer.

Balaraman A, Afzal M, Moglad E, Babu M, Priya G, Bansal P Biogerontology. 2025; 26(2):50.

PMID: 39907830 DOI: 10.1007/s10522-025-10194-2.


Bioinformatics and immunoinformatics approaches in the design of a multi-epitope vaccine targeting CTLA-4 for melanoma treatment.

Noor F, Shahid S, Fatima M, Haider S, Al Shehri Z, Alshehri F Mol Divers. 2025; .

PMID: 39873886 DOI: 10.1007/s11030-025-11108-7.


MiRNAs: main players of cancer drug resistance target ABC transporters.

Mohammadi F, Nejatollahi M, Sheikhnia F, Ebrahimi Y, Mohammadi M, Rashidi V Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39808313 DOI: 10.1007/s00210-024-03719-y.


Investigating the Impact of Circulating MicroRNAs on Knee and Hip Osteoarthritis: Causal Links, Biological Mechanisms, and Drug Interactions.

Li S, Peng Y, Yu Y, Xu H, Yin Z, Du Y Int J Mol Sci. 2025; 26(1.

PMID: 39796139 PMC: 11720664. DOI: 10.3390/ijms26010283.


References
1.
Yuan L, Li S, Chen Q, Xia T, Luo D, Li L . EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma. Cell Death Differ. 2022; 29(8):1513-1527. PMC: 9346003. DOI: 10.1038/s41418-022-00939-8. View

2.
Lu J, Xu F, Lu H . LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53. Life Sci. 2020; 260:118305. DOI: 10.1016/j.lfs.2020.118305. View

3.
Wang S, Dong Y, Gong A, Kong H, Gao J, Hao X . Exosomal circRNAs as novel cancer biomarkers: Challenges and opportunities. Int J Biol Sci. 2021; 17(2):562-573. PMC: 7893596. DOI: 10.7150/ijbs.48782. View

4.
Siak P, Khoo A, Leong C, Hoh B, Cheah S . Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma. Cancers (Basel). 2021; 13(14). PMC: 8305767. DOI: 10.3390/cancers13143490. View

5.
Mu M, Niu W, Zhang X, Hu S, Niu C . LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway. Oncogene. 2020; 39(45):6879-6892. PMC: 7644463. DOI: 10.1038/s41388-020-01466-x. View